Assignee
CELLESTIA BIOTECH AG
CH·2 granted patents·6 pending applications·2 citations·filing 2019–2022
Top patents by PatentIndex Score
8 records- 0182US11472771B2Process for making amino diaryl ethers and amino diaryl ethers hydrochloride saltsCELLESTIA BIOTECH AG·Filed 2019·Granted Oct 18, 2022·2 cites·22 claims
- 0270US12030855B2Process for making amino diaryl ethers and amino diaryl ethers hydrochloride saltsCELLESTIA BIOTECH AG·Filed 2022·Granted Jul 9, 2024·0 cites·22 claims
- 0354US2025000870A1Pharmaceutical Combinations for Treating CancerCELLESTIA BIOTECH AG·Filed 2022·Application pending·0 cites
- 0450US2024269120A1Method for Treating an Autoimmune and Inflammatory DiseaseCELLESTIA BIOTECH AG·Filed 2022·Application pending·0 cites
- 0550US2024041884A1Pharmaceutical Combinations for Treating CancerCELLESTIA BIOTECH AG·Filed 2021·Application pending·0 cites
- 0646US2023338347A1New Use of Inhibitors of the Notch Signalling PathwayCELLESTIA BIOTECH AG·Filed 2021·Application pending·0 cites
- 0745US2022185793A1Compounds for the treatment of oncovirus induced cancer and methods of use thereofCELLESTIA BIOTECH AG·Filed 2020·Application pending·0 cites
- 0844US2022169642A1Compounds for the treatment of oncovirus induced cancer and methods of use thereofCELLESTIA BIOTECH AG·Filed 2020·Application pending·0 cites
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →